CRTDW yields 400000.00% · JNJ yields 2.13%● Live data
📍 CRTDW pulled ahead of the other in Year 1
Combined, CRTDW + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of CRTDW + JNJ for your $10,000?
Creatd, Inc., a technology company, provides economic opportunities for creators in the United States. It operates in four segments: Creatd Labs, Creatd Partners, Creatd Ventures, and Creatd Studios. The company's flagship product is Vocal that delivers a digital publishing platform organized into niche-communities capable of hosting various rich media content. Its Vocal platform enhances the visibility of content and maximizes viewership; and provides advertisers access to target markets that closely match its interests. The company also offers Vocal for Brands, a content marketing that fosters relationships between brands and creators through its suite of agency services; Seller's Choice, performance marketing initiatives; and WHE Agency, an influencer marketing. In addition, it builds, develops, and scales e-commerce brands, such as Camp and Dune Glow Remedy. Further, the company's Creatd studios elevates creators to develop their content for television, film, prints, and podcasts. It serves businesses and consumers. The company was formerly known as Jerrick Media Holdings, Inc. and changed its name to Creatd Inc. in September 2020. Creatd, Inc. is headquartered in New York, New York.
Full CRTDW Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.